


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.48%
+0.64%
-1.40%
-3.21%
-6.46%
FOLD
Amicus Therapeutics
$10.55
Strengths

Earnings are forecast to grow
FOLD Price Performance
$9.42 (+12.00%)
$8.33 (+26.65%)
$6.28 (+67.99%)
$9.63 (+9.55%)
FOLD has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

FOLD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
FOLD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
FOLD Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is FOLD current stock price?
What are FOLD stock strengths?
What is FOLD Risk Level?
What is FOLD market cap and volume?
What is FOLD current Stock IQ?
Should I buy FOLD stock right now?
Is FOLD a Strong Buy right now?
What does a 'Strong Buy' rating mean for FOLD?
What does a 'Strong Sell' rating mean for FOLD?
What factors influence FOLD's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.48%
+0.64%
-1.40%
-3.21%
-6.46%
FOLD
Amicus Therapeutics
Current Price
$10.55
Stock Insights
Strengths

Earnings are forecast to grow

FOLD Price Performance
$9.42 (+12.00%)
$8.33 (+26.65%)
$6.28 (+67.99%)
$9.63 (+9.55%)
FOLD Analysts Opinion
FOLD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
FOLD Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
FOLD Street Sentiment is extremely bullish and have positive views on the near-term outlook
FOLD has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
FOLD Stock IQ
FOLD Latest Analysis
Wall Street Analysts See a 60.61% Upside in Amicus Therapeutics (FOLD): Can the Stock Really Move This High?. The consensus price target hints at a 60.6% upside potential for Amicus Therapeutics (FOLD). While empirical research shows that this sought-after metric is hardly effective an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Fri Dec 12, 2025
Surging Earnings Estimates Signal Upside for Amicus Therapeutics (FOLD) Stock. Amicus Therapeutics (FOLD) shares have started gaining and might continue moving higher in the near term as indicated by solid earnings estimate revisions.
Fri Dec 5, 2025
Wall Street Analysts Think Amicus Therapeutics (FOLD) Could Surge 58.46%: Read This Before Placing a Bet. The average of price targets set by Wall Street analysts indicates a potential upside of 58.5% in Amicus Therapeutics (FOLD). While the effectiveness of this highly sought-after metric is questionable the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wed Nov 26, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
FOLD Stock trends
FOLD Stock performance
FOLD Stock analysis
FOLD investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.